These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9765318)

  • 41. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
    Liu JH; Malone RS; Stallings H; Smith PC
    J Pharmacol Exp Ther; 1996 Jul; 278(1):277-83. PubMed ID: 8764361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetic significance of measurement of salivary penetration of protein-unbound pyridonecarboxylic acid antimicrobial agents].
    Uematsu M
    Shikwa Gakuho; 1989 Jan; 89(1):127-53. PubMed ID: 2762850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-linear pharmacokinetics of ofloxacin after a single intravenous bolus dose in pigs.
    Son DS; Ikenoue N; Tagawa Y; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2000 Oct; 23(5):311-5. PubMed ID: 11107005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereospecific salivary excretion of tocainide enantiomers in man.
    Pillai GK; Axelson JE; Kerr CR; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):209-21. PubMed ID: 6424192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enantioselective disposition of ofloxacin in humans.
    Okazaki O; Kojima C; Hakusui H; Nakashima M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2106-9. PubMed ID: 1759834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of aluminium-containing antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester of ofloxacin as prodrug.
    Maeda Y; Omoda K; Konishi T; Takahashi M; Kihira K; Hibino S; Tsukiai S
    Biol Pharm Bull; 1993 Jun; 16(6):594-9. PubMed ID: 8364513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of a new oral antibacterial agent, ofloxacin, in dentistry and oral surgery.
    Bedeschi G; Beltrame M; Baldin C; Confente G; Guerra L; Fostini R
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):162-4. PubMed ID: 3165967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salivary excretion of 5-fluorouracil. II. Fluctuation of saliva/plasma concentration ratio and salivary clearance during a constant rate intravenous infusion in beagle dogs.
    Hayashi Y; Watanabe J; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1988 Jun; 11(6):438-43. PubMed ID: 3171885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mechanism of renal excretion of T-3761, a novel fluoroquinolone agent, in rabbits].
    Fukuda Y; Muratani T; Takahata M; Fukuoka Y; Yasuda T; Watanabe Y; Narita H
    Jpn J Antibiot; 1995 May; 48(5):649-55. PubMed ID: 7637199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereoselective metabolic disposition of enantiomers of ofloxacin in rats.
    Okazaki O; Kurata T; Tachizawa H
    Xenobiotica; 1989 Apr; 19(4):419-29. PubMed ID: 2501940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ofloxacin in human hair determined by high performance liquid chromatography.
    Miyazawa N; Uematsu T; Mizuno A; Nagashima S; Nakashima M
    Forensic Sci Int; 1991 Oct; 51(1):65-77. PubMed ID: 1752595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
    Ichikawa N; Naora K; Iwamoto K
    Biol Pharm Bull; 1994 Jan; 17(1):152-5. PubMed ID: 8148807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salivary excretion of urea in dogs.
    Watanabe J; Mizuno S; Masuda N; Hayashi Y; Iwamoto K; Hirate J; Ozeki S
    J Pharmacobiodyn; 1984 May; 7(5):294-303. PubMed ID: 6470927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ofloxacin as a reference marker in hair of various colors.
    Wilkins DG; Mizuno A; Borges CR; Slawson MH; Rollins DE
    J Anal Toxicol; 2003 Apr; 27(3):149-55. PubMed ID: 12731656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inter-organ relation between salivary gland and kidney in lithium excretion. I. Effects of continuous stimulation of salivation on salivary, renal and systemic clearances of lithium in dog.
    Watanabe J; Higuchi J; Hayashi Y; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1988 Dec; 11(12):801-7. PubMed ID: 3254978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Excretion of indomethacin into saliva following intravenous administration to dogs.
    Watanabe J; Urasaki Y; Nakase Y; Ueda H; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 May; 4(5):336-44. PubMed ID: 7288551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A study on the distribution of T-3262 (tosufloxacin tosilate) in salivary glands of rats using microautoradiography].
    Morihana T; Sakai H; Hayakawa H
    Jpn J Antibiot; 1989 Sep; 42(9):1868-72. PubMed ID: 2810749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dependence of salivary drug concentration on salivary flow rate.
    Wood JH; Flora KP; Narasimhachari N; Baker CA
    Methods Find Exp Clin Pharmacol; 1982; 4(4):255-60. PubMed ID: 7121134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salivary excretion of injected thiocyanate in hamster and its relation to the salivary peroxidase antibacterial activity.
    Saji S; Morioka T; Matsumura T
    J Osaka Univ Dent Sch; 1968 Sep; 8():33-7. PubMed ID: 5250867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.